Email this article to a friend
New dosing schedules of dasatinib for CML and adverse event management
-
Correspondence: Siu-Fun Wong siuwong@westernu.edu
Journal of Hematology & Oncology 2009, 2:10 doi:10.1186/1756-8722-2-10